Breaking News

Cognis Announces Sales Rise, Financing Costs Fall

October 3, 2007

In the first six months of 2007, global specialty chemicals company Cognis increased its net external sales by 6.2% to $2.4 billion. Currency effects reduced sales growth to 3.5%, according to the company in a press statement.

The operating result (adjusted EBITDA) of $291 million could match the high level of the first half year in 2006 despite a massive rise in raw material costs, especially for natural oils and fats. Together with a successful cost management, the necessary selling price increases could be achieved in many areas, but will show effect with the usual time delay. Return on sales (adjusted EBITDA as a percentage of sales) stood at 12%. Earnings before interest and taxes (EBIT) fell slightly, 1.4%, to $161 million. Excluding exceptional items, Cognis recorded a net profit of $53 million.
blog comments powered by Disqus
  • What’s New at La Prairie?

    What’s New at La Prairie?

    Melissa Meisel, Associate Editor||April 25, 2016
    VP of marketing shares the latest buzz with Happi.

  • Mapping Out Multicultural Beauty

    Mapping Out Multicultural Beauty

    April 25, 2016
    Agnieszka Saintemarie of Kline Group about current trends and challenges in multicultural beauty.

  • At a Loss for Curls?

    April 22, 2016
    Amplixin, a Miami-based maker of hair strengthening products, has a solution for hair loss.

  • Who Makes That?

    Who Makes That?

    Tom Branna, Editorial Director||April 1, 2016
    From concept and formulation to testing and filling, today’s contract manufacturers perform a range of services for marketers

  • Multi-Cultural Beauty Update

    Multi-Cultural Beauty Update

    Christine Esposito, Associate Editor||April 1, 2016
    Established brands and start-ups address the needs of multi-cultural beauty consumers.

  • The Scalp Microbiome

    The Scalp Microbiome

    Nava Dayan PhD, Dr. Nava Dayan LLC||April 1, 2016
    A review of recent findings and innovative approaches for treating scalp disorders.